Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZFAND6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMOD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHACTR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBQLN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSM14A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HERPUD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP6C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMYM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM184C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on